Péter Balogh

Title: Péter Balogh: Innovator in B-Cell Lymphoma Research

Introduction

Péter Balogh is a notable inventor based in Pécs, Hungary. He has made significant contributions to the field of medical research, particularly in the study of B-cell lymphoma. His innovative work has led to the development of a unique mouse lymphoma cell line that has important implications for understanding and treating human high-grade B-cell lymphoma.

Latest Patents

Péter Balogh holds a patent for a groundbreaking invention titled "Mouse lymphoma cell line and animal model of human high grade B-cell lymphoma." This invention relates to a new, spontaneous mouse lymphoma cell line that displays specific markers such as CD19, B220, MHC II, surface IgG2a/kappa chain, and MAC-1, while being negative for CD5. The patent also encompasses animal models of B-cell lymphoma based on this cell line, as well as methods for assessing lymphoma propagation and expansion.

Career Highlights

Péter Balogh is affiliated with the University of Pécs, where he continues to advance his research in oncology. His work is pivotal in providing insights into the mechanisms of lymphoma and developing potential therapeutic strategies. With a focus on innovative research, he has established himself as a key figure in his field.

Collaborations

Péter has collaborated with esteemed colleagues, including Dávid Ernszt and Tamás Kovács. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that promotes scientific discovery.

Conclusion

Péter Balogh's contributions to the field of B-cell lymphoma research exemplify the importance of innovation in medical science. His patented work not only advances our understanding of lymphoma but also opens new avenues for treatment. His dedication to research continues to inspire future advancements in oncology.